---
title: "MAGICAL-ISR study of MagicTouch sirolimus DCB commences"
date: "2024-04-25T09:30:03.000Z"
publishedDate: "25 avril 2024"
summary: "Concept Medical has announced the commencement of its investigational device exemption (IDE) clinical study, MAGICAL-ISR using the MagicTouch sirolimus drug-coated balloon (DCB), for the management of in-stent restenosis (ISR) in coronary artery disease. MagicTouch had earlier been granted a breakthrough device designation in ISR and later IDE approval by the US Food Drug Administration (FDA)."
importance: ""
sourceUrl: "https://cardiovascularnews.com/magical-isr-study-of-magictouch-sirolimus-dcb-commences/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-04-25-magical-isr-study-of-magictouch-sirolimus-dcb-commences"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/02/Generic-innovation.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/magical-isr-study-of-magictouch-sirolimus-dcb-commences/"
---

![MAGICAL-ISR study of MagicTouch sirolimus DCB commences](https://cardiovascularnews.com/wp-content/uploads/sites/14/2020/02/Generic-innovation.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/magical-isr-study-of-magictouch-sirolimus-dcb-commences/*

## L’essentiel

Concept Medical has announced the commencement of its investigational device exemption (IDE) clinical study, MAGICAL-ISR using the MagicTouch sirolimus drug-coated balloon (DCB), for the management of in-stent restenosis (ISR) in coronary artery disease. MagicTouch had earlier been granted a breakthrough device designation in ISR and later IDE approval by the US Food Drug Administration (FDA).

## Lien source

https://cardiovascularnews.com/magical-isr-study-of-magictouch-sirolimus-dcb-commences/
